US 11,628,206 B2Granted

Method for inhibiting STAT3 activity comprising administering Ssu72

AssigneeCurogen Technology Co., Ltd.

InventorsMi-La Cho, Sung-Hwan Park, Seung-Ki Kwok, Jong-Young Choi, Seung-Hun Lee, Hyeon-Beom Seo, Young-Mee Moon, Jin-Sil Park, Min-Jung Park, Jin-Kwan Lee, Chang Woo Lee

Life of this patent

Estimating the term…

Abstract

The present disclosure relates to a method for inhibiting a STAT3 activity comprising administering SSu72 protein.

Claims3

Dependent claims

A method for inhibiting a STAT3 activity, comprising administering to a subject in need thereof a Ssu72 protein.

Dependencies are inferred from the claim text.

Facts

Application: 17/154,924Filed 21 Jan 2021 · continuation
Priority: KR 10-2015-004511431 Mar 2015
Published: US 2021/0220447 A122 Jul 2021
Granted: 18 Apr 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification24 codes

A61K 38/465
Hydrolases: acting on ester bonds , e.g. lipases, ribonucleases
A61P 1/18
Drugs for disorders of the alimentary tract or the digestive system: for pancreatic disorders, e.g. pancreatic enzymes
A61P 3/00
Drugs for disorders of the metabolism
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents

Family

PCT/KR2016/003352Parent of this continuation · filed 31 Mar 2016
US 2021/0220447 A1Pre-grant publication · published 22 Jul 2021
Application15/563,435Parent of this continuation
US 10,925,933 B2Parent of this continuation
US 2018/0140681 A1Published application
US 11,628,206 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results